Facebook
Twitter
LinkedIn
ForwardGlenn Preminger, MD
Glenn M. Preminger, MD is the James F. Glenn, Distinguished Professor of Urologic Surgery and Director of the Comprehensive Kidney Stone Center at Duke University Medical Center, where he focuses on the minimally invasive management of urinary tract stones including SWL, percutaneous and ureteroscopic stone removal. He also directs the metabolic evaluation and preventative medical treatment offered at the Stone Center. Dr. Preminger has extensive experience in developing endoscopic instrumentation for minimally invasive urologic procedures and co-holds nine patents, in SWL design. Dr. Preminger, along with Pei Zhong, Ph.D., established The Lithotripsy Laboratory, having been awarded over $10 million in research support from the NIH. Dr. Preminger has published more than 360 manuscripts, 100 book chapters and 10 books.
He has served as Co-Chairman of the 1st and 2nd International Consultations on Stone Disease, (2001 & 2007). He was Chairman of the AUA Nephrolithiasis Guidelines Panel (2002-2012), Co-Chairman of the joint AUA/EAU International Nephrolithiasis Guidelines Panel (2003-2012), Chair of the AUA Office of Education (2006–2009), Director of Education for the Endourological Society (2011-2017), and President of the Endourological Society (2020). He has served as SESAUA Secretary (2015-2018) and President (2019).
Honors include AUA Residents Committee Teaching Award (2008),International Urolithiasis Society Lifetime Achievement Award (2016), BAUS St. Paul’s Medal (2013), Endourological Society’s Lifetime Achievement Award (2018), Endourological Society Honorary Membership (2021), AUA John K. Latimer Lecturer, (2021), AUA Ramon Guiteras Award (2022), AUA Urology Care Foundation Distinguished Scholar Alumnus Award (2022), Southeastern Section Representative to the AUA Board of Directors (2023-2025) and American Association of Genitourinary Surgeons, Secretary General (2023-2028).
He has served as Co-Chairman of the 1st and 2nd International Consultations on Stone Disease, (2001 & 2007). He was Chairman of the AUA Nephrolithiasis Guidelines Panel (2002-2012), Co-Chairman of the joint AUA/EAU International Nephrolithiasis Guidelines Panel (2003-2012), Chair of the AUA Office of Education (2006–2009), Director of Education for the Endourological Society (2011-2017), and President of the Endourological Society (2020). He has served as SESAUA Secretary (2015-2018) and President (2019).
Honors include AUA Residents Committee Teaching Award (2008),International Urolithiasis Society Lifetime Achievement Award (2016), BAUS St. Paul’s Medal (2013), Endourological Society’s Lifetime Achievement Award (2018), Endourological Society Honorary Membership (2021), AUA John K. Latimer Lecturer, (2021), AUA Ramon Guiteras Award (2022), AUA Urology Care Foundation Distinguished Scholar Alumnus Award (2022), Southeastern Section Representative to the AUA Board of Directors (2023-2025) and American Association of Genitourinary Surgeons, Secretary General (2023-2028).
Financial relationships
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:SESAUADate added:Date updated:10/01/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Endourological SocietyDate added:Date updated:10/01/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Kalera MedicalDate added:Date updated:10/01/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Auris HealthDate added:Date updated:10/01/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:RetrophinDate added:Date updated:10/01/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:UpToDateDate added:Date updated:10/01/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Boston ScientificDate added:Date updated:10/01/2024